Research Groups

Criteria for ESPT Membership

The strong linkage between Research Teams, Research Groups working in the field and ESPT will represent the scientific image of our organization.

The Research groups representing one or two domains important for Pharmacogenomics and Personalized Medicine:

  • Will be put with the best possible visibility on our Web site and in documents. The activities of the research group will be described shortly on the web with the updated publications of the members
  • The group is constituted of a leader, who have to be ESPT full member and 10-30 associate members

All members have full access to all ESPT activities (Restricted area on the ESPT web site (DMPT, teaching platform) and Reductions for courses, schools and meetings)

  • The members particularly the young members will be strongly associated with the scientific activities of ESPT (Annual meetings)
  • They could participate and propose new committees. This strategy will support also dynamically the carriers of young co-workers

The annual membership fee: 20 € per Associate member and 85 € for the leader(s)

 

Research Groups

For more information about the research group, please click on the name of the group.

Name  Location Contact
CANSEARCH research Laboratory Geneva, Switzerland Marc Ansari
Center for Pharmacogenomics – The Ohio State University Columbus, USA Wolfgang Sadee
Extremadura University Hospital and Medical School, Badajoz - CICAB Clinical Research Center Badajoz, Spain  Adrian Llerena
Karolinska Institute – Department of Physiology and Pharmacology Stockholm, Sweden Magnus Ingelman-Sundberg
Lab Applied Molecular Biology and Pharmacogenomics - University of Sao Paulo Sao Paulo, Brazil  Rosario Hirata
Labex –Institut de Biologie de Lille – CNRS UMR 8199 Lille, France Philippe Froguel
Laboratoire d’hématologie – CHU Timone Marseille, France Pierre Morange / Marie-Christine Alessi
Pharmacogenetics Research Group Rotterdam Rotterdam, The Netherlands Ron H.N. Van Schaik
Pharmacogenomics laboratory - Research Center CHUQ (CHUL) – Laval University Faculty of Pharmacy Quebec, Canada Chantal Guillemette
UMR INSERM U 1122 Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire (IGE-PCV)  Nancy, France  Sophie Siest
University of Ljubljana, Faculty of Pharmacy research group Ljubljana, Slovenia Janja Marc

 

Discussions going on

Name

Location

Contact
Omics Science Center – RIKEN Yokohama Institute Yokohama, Japan Toshihisa Ishikawa
Luxembourg Centre for Systems Medicine Luxembourg Jochen Schneider

Paris Team

Pharmacogénomique des anticoagulants

France Marie-Anne Loriot/ Virginie Siguret / Pascale Gaussem
Charles Auffray Lyon, France Maria Nogueira
Leiden Academic Centre for Drug Research - Leiden University Medical Center Leiden, The Netherlands H.J. Guchelaar/ J.J. Swen
Slovakian Research Group Slovakia Ivan Tkac
IKP Stuttgart – Institut für Klinische Pharmakologie Stuttgart Germany Matthias Schwab
Institute for Pharmacology and Toxicology Center for Pharmacogenetics and Pharmacogenomics - Paracelsus Medical University Salzburg, Austria Markus Paulmichl
Centre Energie Atomique - Saclay Gif sur Yvette, France Isabelle Philippe
Department of Molecular and Clinical Pharmacology – The Wolfson Centre for Personalised Medicine – Institute of Translational Medicine – University of Liverpool Liverpool, United Kingdom Munir Pirmohamed
Department of Neurosciences, Mental Health and Sensory Organs - Sapienza University of Rome Rome, Italy Maurizio Simmaco